Futureco Bioscience Appoints María José Lis as Chief Commercial Officer to Strengthen Global Expansion

Futureco Bioscience, a biotechnology company specializing in biocontrol and biostimulant solutions for sustainable agriculture, has announced the promotion of María José Lis to Chief Commercial Officer. The appointment comes as part of a strategic restructuring of the company’s commercial division to grow its global footprint and reinforce the value it provides to farmers and distributors worldwide.

Lis has been a key member of Futureco Bioscience for the past five years, leading Business Development and Marketing. During this time, she has played an instrumental role in strengthening the company’s international positioning, expanding its presence in key markets, and driving recent growth in Mexico, Brazil, North Africa, Asia, and other strategic regions. Her deep knowledge of the company and broad international experience make her ideally suited to lead the next stage of Futureco Bioscience’s commercial development.

In her new role, Lis will focus on building a more integrated and synergistic commercial structure ensuring greater efficiency, stronger collaboration across teams, and a closer relationship with clients and distributors.

Rafael Juncosa, President & CEO of Bioscience, emphasized the strategic importance of the appointment: “Her appointment responds to the need for a more integrated and synergistic commercial structure across countries. This restructuring aims at greater efficiency, stronger collaboration, and a closer relationship with our customers. With her experience and the support of the entire team, we are confident this new stage will be key to advancing our mission.”

Beyond her track record, Lis’s promotion reflects Futureco Bioscience’s commitment to recognizing talent, experience, and diverse leadership. Women are increasingly shaping the future of sustainable agriculture, and this appointment reinforces the company’s belief in the importance of inclusive leadership to deliver innovation and long-term growth.

Top Articles
UPL Reports Robust Q3 Results Driven by Volume Growth and Margin Expansion
María José Lis, newly appointed Chief Commercial Officer of Futureco Bioscience.

María José Lis, newly appointed Chief Commercial Officer of Futureco Bioscience.

Jose Manuel Lara, Chief Operating Officer and Board Member, underlined the company’s values: “At Futureco Bioscience, we believe that driving sustainable agriculture starts with people. From the expertise of our team to the trust of our growers and distributors, this new stage reinforces our determination to support clients worldwide and ensure that innovation translates into commercial growth and real value in the field.”

María José Lis concluded: “I am honored to take on this new responsibility at such an exciting stage for Futureco Bioscience. My focus will be on reinforcing our relationships with clients and distributors worldwide while broadening our horizons, so that our innovations consistently translate into practical solutions and value in the field.”

Futureco Bioscience, headquartered in Olérdola, Barcelona, operates in more than 50 countries, manufacturing science-based solutions designed to improve crop resilience, reduce environmental impact, and support the productivity of export-oriented agriculture. With the appointment of Lis, the company enters a new phase of commercial expansion, reinforcing its role as a trusted partner for agronomists, technicians, and growers globally.